IART stock: buy or sell?

IART stock price: $49.76 0.59% At close on May 21st, 2019

Updated on:
May 21st, 2019

0

Integra LifeSciences shares appreciated 0.59% to $49.76 today.

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.

Should I buy IART stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading strategy that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Integra LifeSciences stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Integra LifeSciences stock a buy?

Financial institutions and banks publish stock ratings everyday. At Stocks2.com, we collected 5 ratings published for IART stock in the last 30 days.

The general sentiment of these ratings is bullish for IART stock, with 4 positive ratings.
Is IART a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-4-25Oppenheimern/aOutperform
2019-3-19Oppenheimern/aBuy
2019-2-27JMP Securitiesn/aBuy
2019-2-21Cantor Fitzgeraldn/aHold
2019-1-3SunTrust Banksn/aBuy

IART stock analysis

Daily outlook

Integra LifeSciences appreciated a tiny 0.59% and closed at $49.76.

Integra LifeSciences shares appreciated 0.59% to $49.76 today. Since SMA50d and SMA100d crossed up on March, IART price slid a -13.20%.

IART stock chart (daily)

Weekly outlook

After sliding a frightening -6.37% in a week last week, Integra LifeSciences closed this week at $49.76 and gained a slightly fine 0.67%.

Since price and 40-weeks moving average lines crossed down late October 2018, IART fell $-11.29 per share (-18.49%). Stocks below the 40w moving average line are usually not recommended for average traders. Far behind is the all-time high Integra LifeSciences marked by mid June 2018 and since then the price is -26.28% below that top.

IART stock chart (weekly)

IART stock price history

IART IPO was on August 16th, 1995 at $7.75 per share1. Since then, IART stock surged a 542.10%, with a yearly average of 23.60%. If you had invested right after IART's IPO a $1,000 in IART stock in 1995, it would worth $5,421.00 today.

1: Adjusted price after possible price splits or reverse-splits.

IART stock historical price chart

IART stock reached all-time highs on June with a price of $67.50.

IART stock price target is $59.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' IART stock price predictions in the hope that they will be met as they may be wrong and not met. We found 3 price targets for Integra LifeSciences stock published in the last month:
IART stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-4-25OppenheimerLowers Target$70.00$65.00-7.1%
2019-2-27JMP SecuritiesReiteratesn/a$62.00-
2019-2-21Cantor FitzgeraldReiteratesn/a$50.00-
(in average)$70.00$59.00-16.0%
The price target for Integra LifeSciences stock is $59.00, moving in a range between $65.00 and $50.00. In average, analysts' outlook on IART price forecast is negative, downgrading the target by a -16.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, Integra LifeSciences reported its latest financial data, posting a slightly good climb for the Earnings per Share (EPS). Analyst expected $0.62 per share, but Integra LifeSciences posted $0.65.
IART earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.35n/a
2017-Q32017-10-260.470.45-4.3%
2017-Q42018-02-270.570.6412.3%
2018-Q12018-04-250.490.5818.4%
2018-Q22018-07-250.60.60.0%
2018-Q32018-10-310.590.590.0%
2018-Q42019-02-210.620.654.8%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

Compared to 2017, last anual sales report draw an astounding gain of 23.92% to $1,472.44 million USD. By contrast, its income margin (compared to sales) depreciated to 4.13%, that is $60.80 million.

IART annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$836 M-$-16.98 M-2.0%-
2014$928 M11.01%$34 M3.7%-300.26%
2015$883 M-4.91%$-3.52 M-0.4%-110.35%
2016$992 M12.39%$75 M7.5%-2,218.90%
2017$1,188 M19.77%$65 M5.4%-13.17%
2018$1,472 M23.92%$61 M4.1%-6.09%

Quarterly financial results

Integra LifeSciences posted $383.32 million in sales for 2018-Q4, a 4.77% improvement compared to previous quarter. Reported quarter income marked $25.14 M with a profit margin of 6.56%. Profit margin raised a 2.92% compared to previous quarter when profit margin was 3.63%. When comparing turnover to same quarter last year, Integra LifeSciences sales marked a fine growth and inched a 3.99%.
IART quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$282 M-$11 M3.8%-
2017-Q3$279 M-1.18%$3 M1.1%-70.86%
2017-Q4$369 M32.19%$44 M12.0%1,304.08%
2018-Q1$357 M-3.13%$11 M3.1%-75.22%
2018-Q2$366 M2.55%$11 M3.1%3.49%
2018-Q3$366 M-0.09%$13 M3.6%16.87%
2018-Q4$383 M4.77%$25 M6.6%89.08%
2019-Q1$360 M-6.16%$33 M9.1%30.30%

Integra LifeSciences ownership

When you are planning to buy a stock, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Integra LifeSciences, 17.28% of all outstanding shares are owned by its staff.

Bearish positions for IART stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related companies:

IARTCAHCNMDJNJMDT
Market cap$4.3 B$14.0 B$2.3 B$368.2 B$117.6 B
Total shares85.5 M298.1 M28.2 M2,660.0 M1,340.0 M
Float shares70.6 M297.1 M27.4 M2,650.0 M1,340.0 M
  - Institutional holdings (%)85.1%92.4%97.5%69.2%84.2%
  - Insider holdings (%)17.3%0.3%1.8%0.1%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

IART summary

Tuesday, May 21st, 2019
Open$49.79
Close$49.76
Day range$49.72 - $50.41
Previous close$49.47
Session gain0.59%
Average true range$1.47
50d mov avg$53.28
100d mov avg$51.23
200d mov avg$54.59
Daily pattern
Weekly pattern lb06a

Integra LifeSciences performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We picked Cardinal Health, CONMED, , Medtronic, RTI Surgical, Stryker, Teleflex, DENTSPLY SIRONA and Zimmer Biomet as the bechmarking frame for Integra LifeSciences stock.
Stock3m6m12m
IARTIntegra LifeScien...-9.33%-6.29%-21.98%
CAHCardinal Health-13.69%-9.44%-6.98%
CNMDCONMED5.87%18.69%18.29%
JNJ2.00%-1.41%16.21%
MDTMedtronic-5.88%-3.53%3.98%
RTIXRTI Surgical-8.52%-0.68%-3.30%
SYKStryker-2.05%12.51%7.28%
TFXTeleflex2.45%15.73%10.27%
XRAYDENTSPLY SIRONA30.97%49.70%17.86%
ZBHZimmer Biomet-6.51%3.47%5.40%

Integra LifeSciences competitors

We picked a few stocks to conform a list of Integra LifeSciences competitors to check if you are interested in investing in IART: